Shanghai HeartCare Medical Technology (6609) Stock Overview
Engages in the research and development, manufacture, and sale of neuro-interventional medical devices in Mainland China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
6609 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Shanghai HeartCare Medical Technology Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$44.18 |
| 52 Week High | HK$71.25 |
| 52 Week Low | HK$24.30 |
| Beta | 0.66 |
| 1 Month Change | -9.43% |
| 3 Month Change | -2.94% |
| 1 Year Change | 51.82% |
| 3 Year Change | 14.31% |
| 5 Year Change | n/a |
| Change since IPO | -65.75% |
Recent News & Updates
Revenues Not Telling The Story For Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) After Shares Rise 32%
Jan 05
Some Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shareholders Look For Exit As Shares Take 29% Pounding
Nov 04Investors Shouldn't Be Too Comfortable With Shanghai HeartCare Medical Technology's (HKG:6609) Earnings
Sep 30Recent updates
Revenues Not Telling The Story For Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) After Shares Rise 32%
Jan 05Some Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shareholders Look For Exit As Shares Take 29% Pounding
Nov 04Investors Shouldn't Be Too Comfortable With Shanghai HeartCare Medical Technology's (HKG:6609) Earnings
Sep 30A Piece Of The Puzzle Missing From Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) 27% Share Price Climb
Aug 18Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) Shares Leap 29% Yet They're Still Not Telling The Full Story
Jul 03We Think Shareholders Are Less Likely To Approve A Pay Rise For Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) CEO For Now
May 19Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) 32% Share Price Surge Not Quite Adding Up
Feb 10Even With A 42% Surge, Cautious Investors Are Not Rewarding Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) Performance Completely
Sep 27Some Shareholders Feeling Restless Over Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) P/S Ratio
Aug 01We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate
Jan 23Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely
Aug 30Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth
Aug 09Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth
May 07We're Hopeful That Shanghai HeartCare Medical Technology (HKG:6609) Will Use Its Cash Wisely
Nov 29Shareholder Returns
| 6609 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | 3.6% | -3.3% | -1.7% |
| 1Y | 51.8% | 22.5% | 15.4% |
Return vs Industry: 6609 exceeded the Hong Kong Medical Equipment industry which returned 22.5% over the past year.
Return vs Market: 6609 exceeded the Hong Kong Market which returned 15.4% over the past year.
Price Volatility
| 6609 volatility | |
|---|---|
| 6609 Average Weekly Movement | 8.4% |
| Medical Equipment Industry Average Movement | 6.4% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in HK Market | 14.4% |
| 10% least volatile stocks in HK Market | 3.0% |
Stable Share Price: 6609 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 6609's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 327 | Guohui Wang | www.heartcare.com.cn |
Shanghai HeartCare Medical Technology Corporation Limited engages in the research and development, manufacture, and sale of neuro-interventional medical devices in Mainland China and internationally. It offers ischemic stroke thrombectomy devices, such as Captor Thrombectomy Stent, a thrombectomy stent retriever; aspiration catheter and pump; intracranial stenosis treatment devices, including intracranial drug-eluting balloon stent, embolization protection system, carotid artery stent, and intracranial balloon dilatation catheter and carotid artery balloon dilatation catheter; hemorrhagic stroke treatment devices, including vascular reconstruction device and flow diverter device; and ischemic stroke prevention devices comprising LAA occlude. The company also provides vascular access devices consisting of distal access catheter, microcatheter, balloon guiding catheter, vascular closure device, support catheter, neuro-interventional microcatheter, neuro-interventional micro guidewire, microcatheter for coiling, microcatheter for flow diverter device, and navigation catheter.
Shanghai HeartCare Medical Technology Corporation Limited Fundamentals Summary
| 6609 fundamental statistics | |
|---|---|
| Market cap | HK$1.67b |
| Earnings (TTM) | HK$48.31m |
| Revenue (TTM) | HK$381.28m |
Is 6609 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6609 income statement (TTM) | |
|---|---|
| Revenue | CN¥334.94m |
| Cost of Revenue | CN¥116.96m |
| Gross Profit | CN¥217.98m |
| Other Expenses | CN¥175.54m |
| Earnings | CN¥42.44m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.12 |
| Gross Margin | 65.08% |
| Net Profit Margin | 12.67% |
| Debt/Equity Ratio | 0% |
How did 6609 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/10 01:30 |
| End of Day Share Price | 2026/03/10 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shanghai HeartCare Medical Technology Corporation Limited is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jin Zhang | China International Capital Corporation Limited |
| null null | China International Capital Corporation Limited |
| Yuan Gao | China International Capital Corporation Limited |